Childrens Mucus Relief Multi Symptom Cold
Loading...Childrens Mucus Relief Multi Symptom Cold Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child’s prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product.
- •
- heart disease
- •
- high blood pressure
- •
- thyroid disease
- •
- diabetes
- •
- cough that occurs with too much phlegm (mucus)
- •
- persistent or chronic cough such as occurs with asthma
- •
- do not use more than directed
- •
- your child gets nervous, dizzy or sleepless
- •
- symptoms do not get better within 7 days or occur with fever
- •
- cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache.
These could be signs of a serious condition.
in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child’s prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product.
Ask a doctor before use if the child has- •
- heart disease
- •
- high blood pressure
- •
- thyroid disease
- •
- diabetes
- •
- cough that occurs with too much phlegm (mucus)
- •
- persistent or chronic cough such as occurs with asthma
- •
- your child gets nervous, dizzy or sleepless
- •
- symptoms do not get better within 7 days or occur with fever
- •
- cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache.
These could be signs of a serious condition.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
- •
- helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
- •
- temporarily relieves:
- •
- cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants
- •
- the intensity of coughing
- •
- the impulse to cough to help your child get to sleep
- •
- nasal congestion due to a cold
- •
- stuffy nose
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Childrens Mucus Relief Multi Symptom Cold Manufacturers
-
Rite Aid Corporation
![Childrens Mucus Relief Multi Symptom Cold (Dextromethorphan Hbr, Guaifenesin, Phenylephrine Hcl) Solution [Rite Aid Corporation]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Childrens Mucus Relief Multi Symptom Cold | Rite Aid Corporation
• do not take more than 6 doses in any 24-hour period • measure only with dosing cup provided • do not use dosing cup with other products • dose as follows or as directed by a doctor • mL = milliliterAge
Dose
children 6 years to under 12 years
10 mL every 4 hours
children 4 years to under 6 years
5 mL every 4 hours
children under 4 years
do not use
Other information • each 5 mL contains: sodium 3 mg • do not use if printed neckband is broken or missing • store at 20-25 °C (68-77 °F) • do not refrigerate • dosing cup provided -
Western Family Foods Inc
Childrens Mucus Relief Multi Symptom Cold | Roxane Laboratories, Inc.
The usual starting dose of telmisartan is 40 mg once a day; blood pressure response is dose related over the range of 20-80 mg. Patients with depletion of intravascular volume should have the condition corrected or telmisartan tablets should be initiated under close medical supervision (see WARNINGS, Hypotension in Volume-Depleted Patients). Patients with biliary obstructive disorders or hepatic insufficiency should have treatment started under close medical supervision (see PRECAUTIONS).
Hydrochlorothiazide is effective in doses of 12.5 mg to 50 mg once daily.
To minimize dose-independent side effects, it is usually appropriate to begin combination therapy only after a patient has failed to achieve the desired effect with monotherapy. The side effects (see WARNINGS) of telmisartan are generally rare and apparently independent of dose; those of hydrochlorothiazide are a mixture of dose-dependent phenomena (primarily hypokalemia) and dose-independent phenomena (e.g., pancreatitis), the former much more common than the latter. Therapy with any combination of telmisartan and hydrochlorothiazide will be associated with both sets of dose-independent side effects.
Telmisartan and hydrochlorothiazide tablets may be administered with other antihypertensive agents.
Telmisartan and hydrochlorothiazide tablets may be administered with or without food.
Replacement TherapyThe combination may be substituted for the titrated components.
Dose Titration by Clinical EffectTelmisartan and hydrochlorothiazide tablets are available as tablets containing either telmisartan 40 mg and hydrochlorothiazide 12.5 mg, or telmisartan 80 mg and hydrochlorothiazide 12.5 mg or 25 mg. A patient whose blood pressure is not adequately controlled with telmisartan monotherapy 80 mg (see above) may be switched to telmisartan and hydrochlorothiazide tablets, telmisartan 80 mg/hydrochlorothiazide 12.5 mg once daily, and finally titrated up to 160/25 mg, if necessary.
A patient whose blood pressure is inadequately controlled by 25 mg once daily of hydrochlorothiazide may be switched to telmisartan 80 mg/hydrochlorothiazide 12.5 mg or telmisartan 80 mg/hydrochlorothiazide 25 mg tablets once daily. The clinical response to telmisartan and hydrochlorothiazide tablets should be subsequently evaluated and if blood pressure remains uncontrolled after 2-4 weeks of therapy, the dose may be titrated up to 160/25 mg, if necessary. Those patients controlled by 25 mg hydrochlorothiazide but who experience hypokalemia with this regimen, may be switched to telmisartan 80 mg/hydrochlorothiazide 12.5 mg tablets once daily, reducing the dose of hydrochlorothiazide without reducing the overall expected antihypertensive response.
Patients with Renal ImpairmentThe usual regimens of therapy with telmisartan and hydrochlorothiazide tablets may be followed as long as the patient’s creatinine clearance is >30 mL/min. In patients with more severe renal impairment, loop diuretics are preferred to thiazides, so telmisartan and hydrochlorothiazide tablets are not recommended.
Patients with Hepatic ImpairmentTelmisartan and hydrochlorothiazide tablets are not recommended for patients with severe hepatic impairment. Patients with biliary obstructive disorders or hepatic insufficiency should have treatment started under close medical supervision using the 40/12.5 mg combination (see PRECAUTIONS).
![Childrens Mucus Relief Multi Symptom Cold (Dextromethorphan Hbr, Guaifenesin, Phenylephrine Hcl) Solution [Western Family Foods Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7be16898-c8ee-43df-a013-edc01c3c96a2&name=7be16898-c8ee-43df-a013-edc01c3c96a2-03.jpg)
Login To Your Free Account